Discover our preset panels

Colorectal
cancer

 

Breast
cancer

Ovarian
cancer

Lung
cancer

Bladder
cancer

Pancreatic
cancer

head & neck
cancer

 

currently enrolling for bladder cancer organoids

book your screen

Converge cost-effectiveness with
patient-centric translational data

PDO Screen is specially crafted to prioritize speed and cost-effectiveness. Choose from our pre-set panels of patient-derived cancer organoids across multiple tissue types. Enhance your drug development process by harnessing the following benefits:

Predictivity: Identify your lead agent with the highest therapeutic potential and lowest toxicity by testing simultaneously on tumor and normal patient-derived organoids

Speed: get translatable data in a fraction of the time needed for an in vivo study

Cost saving: compared to stand-alone studies

Patient relevance: our world-leading technology recapitulates patient heterogeneity and preserves molecular and histological features of the original tumor

 

Translate your in vitro pharmacology
data from your lab to the clinic

currently enrolling for bladder cancer organoids

enrol now

X

Have any questions?

contact us